Attached files
| file | filename |
|---|---|
| EX-32.2 - Vitality Biopharma, Inc. | ex32-2.htm |
| EX-31.2 - Vitality Biopharma, Inc. | ex31-2.htm |
| EX-31.1 - Vitality Biopharma, Inc. | ex31-1.htm |
| EX-23.1 - Vitality Biopharma, Inc. | ex23-1.htm |
| 10-K - Vitality Biopharma, Inc. | form10-k.htm |
Exhibit 32.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
The undersigned, Michael Cavanaugh, the Chief Executive Officer of Vitality Biopharma, Inc. (the “Company”), hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge, the Annual Report on Form 10-K for the period ended March 31, 2020, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in the Annual Report on Form 10-K fairly presents in all material respects the financial condition and results of operations of the Company.
| /s/ Michael Cavanaugh | |
| Chief Executive Officer | |
| (Principal Executive Officer) | |
| Date: June 29, 2020 |